APA (7th ed.) Citation

Kayser, S., Levis, M. J., & Schlenk, R. F. (2017). Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis. Expert review of clinical pharmacology, 10(11), . https://doi.org/10.1080/17512433.2017.1387051

Chicago Style (17th ed.) Citation

Kayser, Sabine, Mark J. Levis, and Richard Friedrich Schlenk. "Midostaurin Treatment in FLT3-mutated Acute Myeloid Leukemia and Systemic Mastocytosis." Expert Review of Clinical Pharmacology 10, no. 11 (2017). https://doi.org/10.1080/17512433.2017.1387051.

MLA (9th ed.) Citation

Kayser, Sabine, et al. "Midostaurin Treatment in FLT3-mutated Acute Myeloid Leukemia and Systemic Mastocytosis." Expert Review of Clinical Pharmacology, vol. 10, no. 11, 2017, https://doi.org/10.1080/17512433.2017.1387051.